JP2024537298A5 - - Google Patents
Info
- Publication number
- JP2024537298A5 JP2024537298A5 JP2024521854A JP2024521854A JP2024537298A5 JP 2024537298 A5 JP2024537298 A5 JP 2024537298A5 JP 2024521854 A JP2024521854 A JP 2024521854A JP 2024521854 A JP2024521854 A JP 2024521854A JP 2024537298 A5 JP2024537298 A5 JP 2024537298A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- composition
- preparation according
- medical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2021/078022 | 2021-10-11 | ||
| PCT/EP2021/078022 WO2023061550A1 (en) | 2021-10-11 | 2021-10-11 | Therapeutic rna for lung cancer |
| EPPCT/EP2022/050135 | 2022-01-05 | ||
| EP2022050135 | 2022-01-05 | ||
| PCT/EP2022/078084 WO2023061931A1 (en) | 2021-10-11 | 2022-10-10 | Therapeutic rna for lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024537298A JP2024537298A (ja) | 2024-10-10 |
| JP2024537298A5 true JP2024537298A5 (https=) | 2025-10-22 |
Family
ID=84286153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024521854A Pending JP2024537298A (ja) | 2021-10-11 | 2022-10-10 | 肺がんの治療用ｒｎａ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240415946A1 (https=) |
| EP (1) | EP4415747A1 (https=) |
| JP (1) | JP2024537298A (https=) |
| KR (1) | KR20240099175A (https=) |
| AR (1) | AR127317A1 (https=) |
| AU (1) | AU2022365280A1 (https=) |
| CA (1) | CA3234915A1 (https=) |
| IL (1) | IL312026A (https=) |
| MX (1) | MX2024004421A (https=) |
| TW (1) | TW202333803A (https=) |
| WO (1) | WO2023061931A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025201659A1 (en) * | 2024-03-28 | 2025-10-02 | BioNTech SE | Combination therapy comprising therapeutic rna cancer vaccines and anti-ctla4 antibodies for cancer treatment |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001231204A1 (en) * | 2000-01-27 | 2001-08-07 | Sidney Kimmel Cancer Center | Genetically engineered tumor cell vaccines |
| EP2281579A1 (en) | 2009-08-05 | 2011-02-09 | BioNTech AG | Vaccine composition comprising 5'-Cap modified RNA |
| WO2013143555A1 (en) | 2012-03-26 | 2013-10-03 | Biontech Ag | Rna formulation for immunotherapy |
| WO2016005004A1 (en) | 2014-07-11 | 2016-01-14 | Biontech Rna Pharmaceuticals Gmbh | Stabilization of poly(a) sequence encoding dna sequences |
| WO2017059902A1 (en) | 2015-10-07 | 2017-04-13 | Biontech Rna Pharmaceuticals Gmbh | 3' utr sequences for stabilization of rna |
| US20180126003A1 (en) * | 2016-05-04 | 2018-05-10 | Curevac Ag | New targets for rna therapeutics |
| TW202134430A (zh) * | 2019-12-03 | 2021-09-16 | 美商紐沃進公司 | 腫瘤細胞疫苗 |
-
2022
- 2022-10-07 TW TW111138246A patent/TW202333803A/zh unknown
- 2022-10-10 EP EP22802066.5A patent/EP4415747A1/en active Pending
- 2022-10-10 CA CA3234915A patent/CA3234915A1/en active Pending
- 2022-10-10 IL IL312026A patent/IL312026A/en unknown
- 2022-10-10 WO PCT/EP2022/078084 patent/WO2023061931A1/en not_active Ceased
- 2022-10-10 MX MX2024004421A patent/MX2024004421A/es unknown
- 2022-10-10 AU AU2022365280A patent/AU2022365280A1/en active Pending
- 2022-10-10 US US18/699,937 patent/US20240415946A1/en active Pending
- 2022-10-10 JP JP2024521854A patent/JP2024537298A/ja active Pending
- 2022-10-10 KR KR1020247012038A patent/KR20240099175A/ko active Pending
- 2022-10-11 AR ARP220102747A patent/AR127317A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12318443B2 (en) | Influenza vaccine | |
| RU2471867C2 (ru) | Гиалуронидаза и способ ее применения | |
| IL298993A (en) | Therapeutic RNA for HPV positive cancer | |
| JP2023134745A (ja) | ジカウイルスに対する免疫応答を誘導するためのヌクレオシド改変ｒｎａ | |
| US8445650B2 (en) | Mutant botulinum neurotoxin serotype A polypeptide and uses thereof | |
| JP2023522249A5 (https=) | ||
| RU2012139432A (ru) | Полипептиды | |
| RU2012102339A (ru) | Полипептиды из neisseria meningitidis | |
| JP2024525795A5 (https=) | ||
| JP2024537297A5 (https=) | ||
| EP1551444B1 (en) | Method for treatment of demyelinating central nervous system disease using gm-csf | |
| AU2022413622A1 (en) | Lyme disease rna vaccine | |
| JP2024537298A5 (https=) | ||
| JP2023500337A5 (https=) | ||
| AU2012281131B2 (en) | Novel zinc finger-like peptide compositions as potent agents in cancer prevention and treatment | |
| JP7412576B2 (ja) | 腎がんの相乗的治療におけるペグインターフェロンおよびプロトオンコジーン産物標的阻害剤の適用 | |
| JP2022549742A (ja) | 腫瘍の相乗的阻害におけるペグインターフェロンおよびプロトオンコジーン産物標的阻害剤の応用 | |
| CN116621966B (zh) | 治疗性核酸分子、混合物、药物及在治疗实体瘤中的应用 | |
| JP2015525785A (ja) | 腫瘍治療のためのペプチドＥＧＦＲｖＩＩＩ配列に基づくワクチン | |
| CN100435849C (zh) | 一种含白细胞介素23基因的抗肿瘤剂 | |
| RU2006111336A (ru) | Р185-кодирующая днк и ее терапевтические применения | |
| RU2023119154A (ru) | Терапевтическая рнк для лечения рака | |
| US20240293352A1 (en) | Pharmaceutical compositions comprising vanadium salts | |
| RU2021129548A (ru) | Терапевтическая рнк для рака предстательной железы | |
| HK40114150A (zh) | 免疫刺激性mrna组合物及其用途 |